Rao K. Seshasai - Publications

Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial.

Journal: BMJ open

Published: April 13, 2023

Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population.

Journal: American journal of preventive cardiology

Published: March 17, 2023

First-line management of paroxysmal atrial fibrillation: is it time for a 'pill in the bin' approach? A discussion on the STOP AF First, EARLY AF, Cryo-FIRST, and EAST-AF NET 4 clinical trials.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: December 01, 2021

Catheter Ablation for Atrial Fibrillation in Patients with Chronic Kidney Disease and on Dialysis: A Meta-Analysis and Review.

Journal: Cardiorenal medicine

Published: October 19, 2021

Investigation of Cardiovascular Health and Risk Factors Among the Diverse and Contemporary Population in London (the TOGETHER Study): Protocol for Linking Longitudinal Medical Records.

Journal: JMIR research protocols

Published: December 24, 2019

Noise Pollution and Arterial Hypertension: Can we Remain Mute Anymore?

Journal: European cardiology

Published: August 01, 2017

Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm.

Journal: International journal of cardiology

Published: May 14, 2017

Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study.

Journal: BMJ open

Published: May 13, 2017

Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK.

Journal: BMJ open

Published: August 07, 2016

Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm.

Journal: The British journal of surgery

Published: January 12, 2016

Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials.

Journal: Diabetes, obesity & metabolism

Published: October 06, 2014

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

Journal: Lancet (London, England)

Published: September 29, 2014